Arrowhead reports lower pancreatitis rates, early cholesterol drug results
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Green Thumb Ended Its String of Profitable Quarters. Is the Stock a Buy?
Green Thumb Industries ended its run of four consecutive profitable quarters.
Financial markets unlikely to be fazed by election uncertainty
Bigger global factors are worrying markets more than New Zealand's election outcome, experts say.
Why Nvidia Stock Looks Like a Bargain Right Now
Key PointsNvidia’s shares are roughly 22% below their all-time high, even though its fiscal second-quarter revenue rose 106% to $96.2 billion, with data center revenue up 117% to $89 billion.